Status:
COMPLETED
PVC Response ''Atrial Pace'' Inducing Atrial Tachycardias
Lead Sponsor:
Helsinki University Central Hospital
Conditions:
Atrial Tachycardia
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Premature ventricular contractions (PVC) are common phenomenon and occasionally retrograde conduction from ventricle to atrium occurs and may cause pacemaker mediated tachycardia. In response certain ...
Detailed Description
The device of the subjects participating to the study is interrogated and the PVC response algorithm is switched from ''Atrial Pace'' to ''Off'' mode. Subjects are also requested to fulfill the EQ-5D...
Eligibility Criteria
Inclusion
- ST Jude Medical or Abbott physiological ICD or CRT-D device
- PVC response setting ''Atrial Pace''
- Atrial tachycardia episode duration \> 30s preceded by ventricular extrasystole and atrial pace in year 2020 or 2021
Exclusion
- Permanent atrial fibrillation, duration ≥ 6 months before the enrollment to the study
- PVC response has been switched off before enrollment
Key Trial Info
Start Date :
May 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2023
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05344456
Start Date
May 11 2022
End Date
August 20 2023
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Central Hospital
Helsinki, Finland